Teva Pharmaceutical Industries (TEVA) FCF Payout Ratio (QoQ) (2009 - 2018)
Teva Pharmaceutical Industries (TEVA) FCF Payout Ratio (QoQ) (2009 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | -93.87% |
| Dec 31, 2017 | -30.34% |
| Sep 30, 2017 | -85.20% |
| Jun 30, 2017 | 127.19% |
| Mar 31, 2017 | -268.18% |
| Dec 31, 2016 | -619.29% |
| Sep 30, 2016 | -30.30% |
| Jun 30, 2016 | 54.28% |
| Mar 31, 2016 | 20.19% |
| Dec 31, 2015 | -31.77% |
| Sep 30, 2015 | 41.54% |
| Jun 30, 2015 | -11.45% |
| Mar 31, 2015 | 32.43% |
| Dec 31, 2014 | -22.78% |
| Sep 30, 2014 | -30.15% |
| Jun 30, 2014 | -19.69% |
| Mar 31, 2014 | -21.35% |
| Dec 31, 2013 | -55.02% |
| Sep 30, 2013 | 196.43% |
| Jun 30, 2013 | 22.96% |